High-dose chemotherapy for tough-to-treat pregnancy-related tumors
Author Information
Author(s): El-Helw L M, Seckl M J, Haynes R, Evans L S, Lorigan P C, Long J, Kanfer E J, Newlands E S, Hancock B W
Primary Institution: YCR Academic Unit of Clinical Oncology, Weston Park Hospital, Sheffield, UK
Hypothesis
Can high-dose chemotherapy and stem cell support improve outcomes in patients with refractory gestational trophoblastic neoplasia?
Conclusion
High-dose chemotherapy and stem cell support for gestational trophoblastic neoplasia is still investigational, with limited success reported.
Supporting Evidence
- Two patients had complete hCG responses lasting 4 and 12 months.
- Three patients had partial tumor marker responses for 1–2 months.
- Most patients had multiple relapses and resistance to treatment.
Takeaway
Some patients with a specific type of cancer related to pregnancy might get better with strong chemotherapy and help from stem cells, but it's still being tested.
Methodology
Retrospective analysis of 11 patients treated with high-dose chemotherapy and stem cell support at three hospitals.
Limitations
The study is retrospective and involves a small number of cases.
Participant Demographics
Patients included had various types of gestational trophoblastic neoplasia, with a mix of low and high-risk classifications.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website